DNA damage detection and signaling is the first step common to all DNA repair pathways. 
ATM inhibitors have shown radiosensitization in preclinical studies.
ATR inhibitor is being tested in three phase 1 trials with radiotherapy in esophageal cancer, locally Advanced head and neck squamous cell carcinoma and brain metastases.
Combining DNA Repair Targeting, Immunotherapy, and Radiotherapy

Home
About Us
Mission & Values
Medical Tourism
Why India?
Testimonials
BLOGs
FAQs
Contact Us
